CYREX
ActiveFrom the official registers: KBO 10 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The annual accounts of CYREX for financial year 2025 show a net loss of 71% of the equity at the start of that year. The 2025 annual accounts show equity of €6,848 and a net result of -€16,694. Equity is growing by about 5.2% per year across the filed financial years. Its solvency ranks better than 10% of 21,120 sector peers (NACE 62, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).
Directors
Board 3
Permanent representatives 2
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Elkayam Orad |
|
| METACORTEX |
|
| NEOTRINITY |
|
| Mathieu Huysman |
|
| Tim De Wachter |
|